NEW YORK (GenomeWeb News) – Tufts University Medical Center has received $24 million from the National Institutes of Health to fund its Clinical and Translational Science Institute (CTSI), which hosts core facilities for nucleic acid analysis, a biorepository, training and consultation programs, and other services, Tufts said on Wednesday.
Tufts said its CTSI collaborates with 39 partners, which includes 12 schools and research centers at the university, 10 affiliated hospitals, and five industry partners, among others.
Richard Karas, the chief scientific officer at Tufts Medical Center, said the CTSI, which first received funding in 2008, provides support for clinical trials, lab research, study design, funding for pilot studies, and career development programs.
The CTSI's core center, the Clinical and Translational Research Center, provides a range of services, including specimen processing, storage, and shipping, nucleic acid analysis, immunoassays, and access to bench and freezer space. The CTSI's specimen processing services include DNA and RNA isolation, and its nucleic acid analysis offerings include DNA and RNA analysis, real-time PCR assays, whole genome amplification, and library preparation for next-generation sequencing.